Table 4.
Logistic Regression.
| Variable | B | SE | Wald X2 | P | OR | 95% CI |
|---|---|---|---|---|---|---|
| HBM: Perceived benefits flu vax | 0.284 | 0.207 | 1.880 | .170 | 1.328 | 0.885, 1.992 |
| HBM: Perceived barriers flu vax | 0.739 | 0.221 | 11.164 | .001* | 2.094 | 1.357, 3.232 |
| HBM: Flu susceptibility | 0.758 | 0.207 | 13.476 | <.001* | 2.135 | 1.424, 3.200 |
| HBM: Flu severity | −0.050 | 0.181 | 0.077 | .782 | 0.951 | 0.667, 1.356 |
| HBM: Flu vax uptake self-efficacy | −0.615 | 0.182 | 11.477 | .001* | 0.541 | 0.379, 0.772 |
| HBM: Flu vax cue to action | −0.371 | 0.213 | 3.037 | .081 | 0.690 | 0.455, 1.047 |
| Web link | 0.290 | 0.145 | 3.975 | .046* | 1.336 | 1.005, 1.776 |
| Visual | 1.029 | 0.173 | 35.429 | <.001 | 2.798 | 1.994, 3.927 |
| Healthcare professionals promoting flu vax | −0.227 | 0.172 | 1.746 | .186 | 0.797 | 0.569, 1.116 |
| Alternative protection | 0.606 | 0.417 | 2.114 | .146 | 1.833 | 0.810, 4.149 |
| Specific populations for flu vax | −0.343 | 0.173 | 3.949 | .047* | 0.710 | 0.506, 0.995 |
*
Significant at P < .05.